Naurex Report issue

For profit Phase 1 Phase 2
Founded: Evanston IL United States (2008)
Status: Acquired by Allergan PLC (2015) (2015) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2009
NCT01014650
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Naurex, Inc

Active Ingredients

Drugs in Phase 2 Trials (2)

nrx-1074 (4 trials)

rapastinel (4 trials)

Drugs in Phase 1 Trials (1)

sodium chloride (1 trial)

Drugs in Other Trials (1)

wild blueberry extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Disease (Phase 2)

Schizophrenia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 4